Walt Addison Linscott

CIK 1648585 · Chief Operating Officer · last filed 2025-12-29

Walt Addison Linscott is a Chief Operating Officer who has filed 13 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing shows the insider was granted $110.5K of INDP on Dec 29, 2025. Across all open-market trades the lifetime net is +$393, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $70.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$70.2K

Companies

2

Total Filings

13

Lifetime Open-Market Net

$393

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INDP Chief Operating Officer 54,426 $1.29 $70.2K $393 8 2025-12-29
Intec Pharma Ltd. (NTEC) Delisted Chief Business Officer $9.63 $0 4 2020-09-18

Recent Filings

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-12-29 INDP Grant (A) +54,421 $110.5K EDGAR
2025-04-11 INDP Disp (D) $0 EDGAR
2024-10-10 INDP Grant (A) $0 EDGAR
2024-01-23 INDP Grant (A) $0 EDGAR
2023-01-20 INDP Grant (A) $0 EDGAR
2022-09-09 INDP Buy (P) +150 $393 EDGAR
2022-01-28 INDP Grant (A) $0 EDGAR
2021-08-06 INDP Grant (A) $0 EDGAR
2020-09-18 Intec Pharma Ltd. (NTEC) Delisted Grant (A) $0 EDGAR
2020-02-19 Intec Pharma Ltd. (NTEC) Delisted Grant (A) $0 EDGAR
Showing 110 of 13
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.